Source:http://linkedlifedata.com/resource/pubmed/id/15868656
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0017262,
umls-concept:C0023602,
umls-concept:C0023607,
umls-concept:C0185117,
umls-concept:C0205178,
umls-concept:C0205225,
umls-concept:C0205263,
umls-concept:C0220905,
umls-concept:C0597513,
umls-concept:C0600388,
umls-concept:C1514873,
umls-concept:C1546857,
umls-concept:C1556066,
umls-concept:C1619636,
umls-concept:C2587213,
umls-concept:C2911684
|
pubmed:issue |
1
|
pubmed:dateCreated |
2005-5-3
|
pubmed:abstractText |
The luteinizing hormone (LH) plays a critical role in steroidogenesis, by stimulating cAMP-dependent protein kinase A (PKA) and phospholipase A2 activity, and by mobilizing calcium and chloride ions. In contrast, whether the ERK 1, 2 mitogen-activated protein (MAP) kinases are involved in LH-induced steroidogenesis is less obvious. Here, we sought to clarify this point in rat primary Leydig cells, naturally bearing the LH receptor (LH-R) in male, and in the mouse tumoral Leydig cell line (MLTC 1). Pre-incubation of both cell types with the mitogen-activated protein kinase kinase (MEK) inhibitors U0126 and PD98059 reduced LH-induced steroidogenesis, and tonically enhanced the expression of the StAR protein. Furthermore, ERK1, 2 were inducibly phosphorylated following LH exposure of MLTC 1 cells. Altogether, our results indicate that in primary as well as in tumoral Leydig cells, inhibiting MEK dampened LH-induced steroidogenesis but enhanced basal as well as LH-induced StAR expression, suggesting that ERK1,2 could be involved in these responses.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Luteinizing Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase 3,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Progesterone,
http://linkedlifedata.com/resource/pubmed/chemical/Testosterone,
http://linkedlifedata.com/resource/pubmed/chemical/steroidogenic acute regulatory...
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0926-5287
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
45
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
101-8
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:15868656-Animals,
pubmed-meshheading:15868656-Cell Line, Tumor,
pubmed-meshheading:15868656-Immunoblotting,
pubmed-meshheading:15868656-Leydig Cells,
pubmed-meshheading:15868656-Luteinizing Hormone,
pubmed-meshheading:15868656-Male,
pubmed-meshheading:15868656-Mice,
pubmed-meshheading:15868656-Mitogen-Activated Protein Kinase 3,
pubmed-meshheading:15868656-Phosphoproteins,
pubmed-meshheading:15868656-Progesterone,
pubmed-meshheading:15868656-Rats,
pubmed-meshheading:15868656-Rats, Wistar,
pubmed-meshheading:15868656-Testosterone
|
pubmed:articleTitle |
Extracellular signal-regulated kinases (ERK) 1, 2 are required for luteinizing hormone (LH)-induced steroidogenesis in primary Leydig cells and control steroidogenic acute regulatory (StAR) expression.
|
pubmed:affiliation |
Institut National de la Recherche Agronomique/Centre National pour la Recherche Scientifique/Université de Tours/Haras Nationaux, UMR 6175, Centre de Recherches de Tours, 37380 Nouzilly, France. martinat@tours.inra.fr
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|